ICE vs TERN · P/E 37, rev $12.64B vs $6.12B cap
Intercontinental Exchange Inc (ICE) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
ICE currently screens at market cap $103.55B and trailing P/E 37.3. TERN currently screens at market cap $6.12B.
Not investment advice. Open the ICE and TERN stock pages for the full models.
Not investment advice.